← Evidence map

ArticleScientific reports2025

Efficacy and safety of azvudine versus nirmatrelvir/ritonavir in cancer patients with COVID-19.

Bohan Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40164617